NCT06891157
- Conditions
- Chidamide, DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, +8 more
- Locations
-
- The First Affiliated Hospital with Nanjing Medical University Nanjing, Jiangsu, China
Clinical trial condition
Double-expressor Lymphoma (DEL)
Explore clinical trials studying Double-expressor Lymphoma (DEL). Study availability and eligibility vary by location and protocol.
2 public trials
1 recruiting study
Double-expressor Lymphoma (DEL) trial results
NCT01742988
- Conditions
- Double-expressor Lymphoma (DEL), Double-hit Lymphoma (DHL), Hemic and Lymphatic Diseases, +18 more
- Locations
-
- USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
- Florida Cancer Specialists Sarasota, Florida, United States
- Winship Cancer Institute, Emory University Atlanta, Georgia, United States
- University of Chicago Medicine Chicago, Illinois, United States